Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation
- 27 July 2004
- journal article
- Published by Wiley in Histopathology
- Vol. 45 (2) , 180-186
- https://doi.org/10.1111/j.1365-2559.2004.01925.x
Abstract
To investigate survivin expression in laryngeal squamous cell carcinoma (LSCC), its prognostic significance and relation to p53 status. Survivin is an inhibitor of apoptosis protein that is overexpressed in cancer. It has been implicated in both prevention of apoptosis and cell cycle regulation. It has been suggested that wild-type p53 represses survivin expression.Expression of survivin and p53 was analysed in 68 archival biopsy specimens of LSCC by immunohistochemistry. Survivin was detected in 67 of 68 LSCC cases; the proportion of survivin-positive cells varied from 8.2% to 100%. It was localized in the nucleus and/or cytoplasm of tumour cells. Of LSCC cases, 31.8% were p53+. The number of survivin-positive cells was significantly higher in the p53+ group. A high level of survivin expression and a supraglottic site of the tumour were two independent adverse prognostic factors in LSCC.Survivin is expressed in a varying proportion of cells in virtually all cases of LSCC. A high level of its expression predicts poor survival. Loss of wild-type p53 is a possible mechanism of survivin up-regulation in LSCC.Keywords
This publication has 37 references indexed in Scilit:
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Differential subcellular localization of functionally divergent survivin splice variantsCell Death & Differentiation, 2002
- Quantitative analysis of apoptosis‐related gene expression in hepatocellular carcinomaCancer, 2002
- Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53Journal of Biological Chemistry, 2002
- Immunohistochemical Detection of the Anti-Apoptosis Protein, Survivin, Predicts Survival After Curative Resection of Stage II Colorectal CarcinomasAnnals of Surgical Oncology, 2001
- Immunohistochemical Detection of the Anti-Apoptosis Protein, Survivin, Predicts Survival After Curative Resection of Stage II Colorectal CarcinomasAnnals of Surgical Oncology, 2001
- Survivin promotes cell proliferation in human hepatocellular carcinomaHepatology, 2000
- p53 and apoptosisSeminars in Cancer Biology, 1998
- p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factorsThe Journal of Pathology, 1995
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994